- Home
- LSPD vs HROW Comparison
LSPD vs HROW Comparison
Compare LSPD & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSPD
- HROW
- Stock Information
- Founded
- LSPD 2005
- HROW 1998
- Country
- LSPD Canada
- HROW United States
- Employees
- LSPD N/A
- HROW N/A
- Industry
- LSPD
- HROW Biotechnology: Pharmaceutical Preparations
- Sector
- LSPD
- HROW Health Care
- Exchange
- LSPD Nasdaq
- HROW Nasdaq
- Market Cap
- LSPD 1.7B
- HROW 1.4B
- IPO Year
- LSPD 2020
- HROW N/A
- Fundamental
- Price
- LSPD $11.70
- HROW $42.00
- Analyst Decision
- LSPD Hold
- HROW Strong Buy
- Analyst Count
- LSPD 13
- HROW 7
- Target Price
- LSPD $13.58
- HROW $68.50
- AVG Volume (30 Days)
- LSPD 514.2K
- HROW 827.9K
- Earning Date
- LSPD 11-06-2025
- HROW 11-12-2025
- Dividend Yield
- LSPD N/A
- HROW N/A
- EPS Growth
- LSPD N/A
- HROW N/A
- EPS
- LSPD N/A
- HROW N/A
- Revenue
- LSPD $1,115,677,000.00
- HROW $227,661,000.00
- Revenue This Year
- LSPD $14.22
- HROW $43.92
- Revenue Next Year
- LSPD $12.03
- HROW $41.32
- P/E Ratio
- LSPD N/A
- HROW N/A
- Revenue Growth
- LSPD 15.46
- HROW 47.69
- 52 Week Low
- LSPD $7.34
- HROW $20.85
- 52 Week High
- LSPD $18.96
- HROW $59.23
- Technical
- Relative Strength Index (RSI)
- LSPD 44.52
- HROW 46.09
- Support Level
- LSPD $11.44
- HROW $46.45
- Resistance Level
- LSPD $12.00
- HROW $48.79
- Average True Range (ATR)
- LSPD 0.34
- HROW 2.49
- MACD
- LSPD -0.03
- HROW -0.72
- Stochastic Oscillator
- LSPD 20.51
- HROW 14.10
About LSPD Lightspeed Commerce Inc. Subordinate Voting Shares
Lightspeed Commerce Inc provides an omni-channel commerce-enabling SaaS platform. Its software platform provides customers with the functionality it needs to engage with consumers, manage their operations, accept payments, and grow their businesses. The company sells its platform through a direct sales force in the United States, Canada, United Kingdom, Australia, and other countries. It derives a majority of its revenue from the United States.
About HROW Harrow Inc.
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.